argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
586.55
0.00 (0.00%)
At close: Jun 9, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$1,652,947
Profits / Employee
$665,482
Market Cap
35.47B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Elite Pharmaceuticals | 64 |
| Tian'an Technology Group | 8 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
argenx SE News
- 5 days ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - Benzinga
- 5 days ago - argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren's Disease - GlobeNewsWire
- 13 days ago - argenx to Present at Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 18 days ago - argenx Announces Results of Annual General Meeting of Shareholders - GlobeNewsWire
- 26 days ago - Hot Picks in biotech: argenx, Scholar Rock & Kiniksa - BNN Bloomberg
- 5 weeks ago - Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? - Benzinga
- 5 weeks ago - Argenx Q1 Earnings: Less Than Perfect Report Gets Punished - Seeking Alpha
- 5 weeks ago - Argenx targets Vision 2030 with 50,000 patients and 10 labeled indications by 2025 - Seeking Alpha